The Signatera test can be performed on all solid tumours. Please consult with our colleagues about your results!

The most common tumour types where Signatera is already routinely used are:

Breast cancer

Colon cancer

Lung cancer

Pancreatic cancer

Stomach cancer

Esophageal cancer

Ovarian cancer

Endometrial tumour

Neuroendocrine tumours



Kidney cancer

The Signatera test cannot be used in the following cases:

In synchronous primary tumours*

In case of pregnancy

In patients who have had a previous (non-autologous) bone marrow transplant

In patients who have had a blood transfusion in the last 3 months

In non-solid tumours, eg.: haematological malignancies

For brain tumors

* Inquire from our colleagues

Please enter your personal details and send us your questions, and our experts will be happy to answer within 24 - 48 hours.

Thank your for your message. We will contact you in 24-48 hours.
Error. Please try again.